Cargando…
Gene therapy during ex situ heart perfusion: a new frontier in cardiac regenerative medicine?
Ex situ organ preservation by machine perfusion can improve preservation of organs for transplantation. Furthermore, machine perfusion opens up the possibilities for selective immunomodulation, creation of tolerance to ischemia-reperfusion injury and/or correction of a pathogenic genetic defect. The...
Autores principales: | Vervoorn, Mats T., Amelink, Jantijn J. G. J., Ballan, Elisa M., Doevendans, Pieter A., Sluijter, Joost P. G., Mishra, Mudit, Boink, Gerard J. J., Bowles, Dawn E., van der Kaaij, Niels P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614057/ https://www.ncbi.nlm.nih.gov/pubmed/37908499 http://dx.doi.org/10.3389/fcvm.2023.1264449 |
Ejemplares similares
-
Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success
por: Silvis, Max J. M., et al.
Publicado: (2020) -
The ESC Working Group on cardiovascular regenerative and reparative medicine
por: Pompilio, Giulio, et al.
Publicado: (2023) -
Human cardiomyocyte progenitor cells: a short history of nearly everything
por: Vliet, Patrick, et al.
Publicado: (2012) -
Biofabrication of Cell-Derived Nanovesicles: A Potential Alternative to Extracellular Vesicles for Regenerative Medicine
por: Ilahibaks, Nazma F., et al.
Publicado: (2019) -
Mixed Reality in Modern Surgical and Interventional Practice: Narrative Review of the Literature
por: Vervoorn, Mats T, et al.
Publicado: (2023)